/
MEDOF
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $327.8M | $516.8M | $626.5M | $1.36B | $1.61B | $1.78B | $1.88B | $2.08B |
| Cost of revenue | $304.7M | $482.8M | $589.0M | $1.29B | $1.50B | $1.68B | $1.73B | $1.88B |
| Gross profit | $23.1M | $34.0M | $37.6M | $68.5M | $106.9M | $108.6M | $151.5M | $199.2M |
| Gross margin | 7.1% | 6.6% | 6.0% | 5.0% | 6.6% | 6.1% | 8.0% | 9.6% |
| R&D | $90.0K | $428.0K | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $7.4M | $14.4M | $9.5M | $15.3M | $29.0M | $31.4M | $31.7M | $42.4M |
| EBITDA | $8.6M | $16.4M | $13.1M | $34.7M | $51.3M | $52.8M | $64.0M | $84.9M |
| Net income | $4.3M | $9.8M | $5.5M | $7.4M | $18.3M | $18.8M | $12.5M | $15.4M |
| Net margin | 1.3% | 1.9% | 0.9% | 0.5% | 1.1% | 1.1% | 0.7% | 0.7% |
| EPS (diluted) | 0.31 | 0.65 | 0.35 | 0.37 | 0.77 | 0.79 | 0.49 | 0.61 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.1B | $1.38 | $1.34–$1.42 | 1 |
| 2027 | $2.2B | $1.69 | $1.64–$1.73 | 1 |
| 2028 | $2.3B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$46.24
Price
$50.00
Implied downside
-8%
Peer comparison
MEDIOS AG ORD
MEDIOS AG ORD
Held by traders on TradeandTell
No one on the platform currently holds MEDOF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in MEDOF as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded MEDOF yet.